Cetera Investment Advisers
MIRM icon

Cetera Investment Advisers’s Mirum Pharmaceuticals MIRM Stock Holding History

Cetera Investment Advisers’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$844K Buy
7,209
+467
+7% +$46.9K ﹤0.01% 3197
2026
Q1 		$623K Buy
6,742
+572
+9% +$53.8K ﹤0.01% 3311
2025
Q4 		$487K Buy
6,170
+1,732
+39% +$124K ﹤0.01% 3463
2025
Q3 		$325K Buy
+4,438
New +$282K ﹤0.01% 3760

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Investment Advisers's MIRM Position: Q2 2026 in Review

Cetera Investment Advisers increased its Mirum Pharmaceuticals (MIRM) stake by 6.9% in Q2 2026, buying an estimated $46.9K and bringing the position to 7,209 shares worth $844K. The position accounts for ﹤0.01% of the portfolio, ranked #3197.

Cetera Investment Advisers first reported a position in MIRM in Q3 2025 and has held it in 4 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Cetera Investment Advisers held 7,209 shares of Mirum Pharmaceuticals worth $844K as of Q2 2026.
  • Cetera Investment Advisers bought 467 Mirum Pharmaceuticals shares in Q2 2026, an estimated $46.9K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3197 holding.
  • Cetera Investment Advisers first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.